Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMoving from 7.5mg to 10mg Mounjaro is a standard step in the licensed titration schedule — your prescriber has guided you through three previous increases already, and this one follows the same four-week minimum pattern. The 10mg dose is one of three therapeutic strengths above the starting pen, and for many people it marks a point where weight loss accelerates noticeably. Like every dose step, it is a prescription decision: a clinical assessment confirms whether the increase is appropriate for you before it happens. Mounjaro is a Prescription-Only Medicine, and the right dose is always determined by a GPhC-registered prescriber reviewing your progress, tolerance and health picture, not a fixed schedule you move through automatically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the moment: your current pen is nearly done, you've tolerated 7.5mg reasonably well, and the question is whether to move up. That feeling of uncertainty is one the prescribers at nume... wait, at nume hear often. The titration schedule in the licensed Mounjaro programme exists because each step has a purpose. The first two pens (2.5mg and 5mg) were mostly about settling your body into a new way of processing appetite signals. The move to 7.5mg typically brought a stronger reduction in hunger. The 10mg pen continues that arc.
Four weeks is the minimum time your prescriber will want you to have spent at 7.5mg before considering the next step. That period matters because the medicine accumulates to a steady level in your system over roughly two to three weeks. If you moved sooner, the full effect of 7.5mg would not yet be clear. Think of that window as your prescriber gathering data, not as a waiting game you sit through passively. Worth taking two minutes to check: does the date on your 7.5mg prescription show at least four weeks have passed? If not, our guide to going up to 7.5mg explains what that four-week period is actually for, which can help set expectations before you move on.
Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it activates two gut-hormone pathways involved in appetite regulation and blood-sugar control. At higher doses, both pathways receive a stronger signal. That is why the Mounjaro clinical programme was designed with gradual steps rather than a single therapeutic dose from day one.
The most common experience people report after moving to 10mg is that the first few days feel a little like starting a new dose all over again. Nausea, loose stools or a heavier sense of fullness after small amounts of food can return briefly, even if they had largely gone away at 7.5mg. This is a well-documented pattern across the Mounjaro titration steps, not a sign that 10mg is wrong for you. The NHS's patient guidance on tirzepatide notes that these effects are typically most noticeable in the days following a dose change and settle as your body adjusts.
Practically: eating slowly, stopping before you feel completely full, and keeping well hydrated are the habits that make the biggest difference in those first two weeks. Protein stays important, because appetite suppression at this level can make it easy to eat too little overall, not just less of the wrong things. If symptoms feel severe (particularly persistent vomiting, signs of dehydration, or stomach pain that is unusual for you) contact your prescriber or care team promptly rather than waiting it out. For context on how side effect patterns tend to evolve across dose steps, this page on side effects and dosage progression explains what the evidence actually shows.
Most people find the transient discomfort at 10mg no worse than earlier steps, and often shorter-lived, because the body has already adapted to the mechanism of action over the preceding months.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed adults over 72 weeks across the Mounjaro dose range. At 15mg, average weight reduction reached around 20 to 21%. The data consistently showed that higher doses within the licensed range produced greater average weight loss, which is why the titration schedule exists as a structured climb rather than a choice between a few fixed options.
The 10mg pen is not where the programme ends. If you tolerate it well and your prescriber judges that further progress is appropriate, the schedule continues to 12.5mg and then 15mg. Equally, some people reach a dose that suits them and stay there, particularly if they are achieving good results with manageable side effects. The right stopping point on the titration ladder is a clinical judgement, made by reviewing your actual weight trend and tolerance at each step, not a target you decide on before you start. If you are thinking about what the full range looks like from the beginning, the first titration step gives useful context on how the dose schedule is structured from 2.5mg onward.
One practical point for anyone considering private treatment or moving between providers: getting Mounjaro through a regulated online pharmacy means your dose increase is confirmed by a prescriber reviewing your actual progress, not processed on a timer. That review is what the step-up is designed to follow.
A dose increase to 10mg is not something that happens on request alone. A prescriber reviewing your case will typically want to know that you have completed the full period at 7.5mg, that side effects at the current dose are tolerable rather than ongoing, and that your weight trend supports continuing to escalate. At nume, clinical review is carried out by a named GPhC-registered prescriber, a real person reading your update, not automated software moving you through a protocol.
If you are currently on 7.5mg and thinking about what comes next, the place to start is a conversation with whoever holds your prescription. If you are new to treatment and trying to understand the full picture before you begin, the weight loss treatment overview covers how Mounjaro fits alongside lifestyle changes for people starting out. And if your question is specifically about the earlier steps, the side effect picture when moving from 2.5 to 5mg gives a sense of what the whole titration arc tends to look like in practice.
The 10mg step is well within the licensed programme. With clinical oversight and honest reporting of how you are getting on, it is a straightforward next chapter for most people who have reached it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.